Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacovigilance in the pharmaceutical industry.

× No keyword cloud information.

11 in total

1. Review of company postmarketing surveillance studies.

Authors: P C Waller; S M Wood; M J Langman; A M Breckenridge; M D Rawlins
Journal: BMJ Date: 1992-06-06

2. Study of United Kingdom product licence applications containing new active substances, 1987-9.

Authors: M D Rawlins; D B Jefferys
Journal: BMJ Date: 1991-01-26

3. Concepts in risk-benefit assessment. A simple merit analysis of a medicine?

Authors: R Edwards; B E Wiholm; C Martinez
Journal: Drug Saf Date: 1996-07 Impact factor: 5.606

4. End of the line for "third-generation-pill" controversy?

Authors: J P Vandenbroucke; F R Rosendaal
Journal: Lancet Date: 1997-04-19 Impact factor: 79.321

5. The case for recording events in clinical trials.

Authors: D C Skegg; R Doll
Journal: Br Med J Date: 1977-12-10

Review 6. The way towards adverse event monitoring in clinical trials.

Authors: M A Wallander
Journal: Drug Saf Date: 1993-03 Impact factor: 5.606

7. Computer-assisted evaluation of adverse events using a Bayesian approach.

Authors: K L Lanctôt; C A Naranjo
Journal: J Clin Pharmacol Date: 1994-02 Impact factor: 3.126

8. Guidelines for company-sponsored Safety Assessment of Marketed Medicines (SAMM) guidelines. Medicines Control Agency, Committee on Safety of Medicines, Royal College of General Practitioners, British Medical Association and Association of the British Pharmaceutical Industry (November 1993)

Authors:
Journal: Br J Clin Pharmacol Date: 1994-08 Impact factor: 4.335

9. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.

Authors: D Henry; L L Lim; L A Garcia Rodriguez; S Perez Gutthann; J L Carson; M Griffin; R Savage; R Logan; Y Moride; C Hawkey; S Hill; J T Fries
Journal: BMJ Date: 1996-06-22

10. The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

Authors: M A Lewis; L A Heinemann; K D MacRae; R Bruppacher; W O Spitzer
Journal: Contraception Date: 1996-07 Impact factor: 3.375

8 in total

1. Pharmacy student perceptions of adverse event reporting.

Authors: Sirisha Kalari; Matthew Dormarunno; Oleg Zvenigorodsky; Aparna Mohan
Journal: Am J Pharm Educ Date: 2011-09-10 Impact factor: 2.047

2. Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings.

Authors: Daniel M Cook; Rama K Gurugubelli; Lisa A Bero
Journal: Drug Saf Date: 2009 Impact factor: 5.606

3. Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey.

Authors: Stella Stergiopoulos; Mortiz Fehrle; Patrick Caubel; Louise Tan; Louise Jebson
Journal: Pharmaceut Med Date: 2019-12

Review 8. Adverse event reporting tools and regulatory measures in India through outcome of Pharmacovigilance Programme of India.

Authors: Jai Prakash; Raghav Sachdeva; Tarani Prakash Shrivastava; C V Jayachandran; Aseem Sahu
Journal: Indian J Pharmacol Date: 2021 Mar-Apr Impact factor: 1.200